Several approved treatments , including copyright and Semaglutide, fall under the incretin mimetic class . Mainly, these drugs work by mimicking endogenous substances that regulate glucose levels and https://safaqpae208830.blogolenta.com/38162147/copyright-and-glp-1-receptor-agonists-getting-to-know-the-medications